Abstract:OBJECTIVE:(Background): Alzheimer's disease (AD), clinically characterized by the progressive neurodegenerative condition and cognitive impairment, is one of the main causes of disability in elder people worldwide. Recently, several animal studies indicated that the 'gut-brain' axis might contribute to the amyloid deposition of AD. However, data about gut dysbiosis in human AD remains scarce in the literature, especially including the whole process of AD. In this prospective and cross-sectional study, we aimed at identifying differences in microbiome between patients with AD (Pre-onset stage amnestic mild cognitive impairment, aMCI; and AD) and the normal cognition healthy controls (HC). Additionally, the potential association between IM and clinical characteristics of AD was evaluated.METHODS:A total of 97 subjects (33 AD, 32 aMCI, and 32 HC) were recruited in the study. The composition of gut bacterial communities was determined by 16S ribosomal RNA Miseq sequencing. In addition, Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) was used to predict function shift of intestinal microbiota. The Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) or Clinical Dementia Rating (CDR) scores were used to evaluate the severity of cognitive impairment in patients.RESULTS:The fecal microbial diversity was decreased in AD patients compared with aMCI patients and HC. And the microbial composition was distinct among aMCI, AD and healthy control groups. Among bacterial taxa, the proportion of phylum Firmicutes was significantly reduced (P = 0.008), whereas Proteobacteria (P = 0.024) was highly enriched in the AD compared with HC. In addition, similar alterations were observed at the order, class and family levels of these two phyla. And Gammaproteobacteria, Enterobacteriales and Enterobacteriaceae showed a progressive enriched prevalence from HC to aMCI and AD patients. Further, a significant correlation was observed between the clinical severity scores of AD patients and the abundance of altered microbiomes. Moreover, the KEGG results showed the increased modules related to glycan biosynthesis and metabolism in AD and aMCI patients and decreased pathways related to immune system in AD patients. Importantly, the discriminating models based on predominant microbiota could effectively distinguish aMCI and AD from HC (AUC = 0.890, 0.940, respectively), and also AD from aMCI (AUC = 0.925). Notably, the models based on the abundance of family Enterobacteriaceae could distinguish AD from both aMCI (AUC = 0.688) and HC (AUC = 0.698).CONCLUSIONS:Distinct microbial communities, especially enriched Enterobacteriaceae, were associated with patients with AD when compared with predementia stage aMCI and healthy subjects. These novel findings will give new clues to understand the disease and provide new therapeutic target for intervention or a marker for this disease.

Multimodal neuroimaging fusion biomarkers mediate the association between gut microbiota and cognition

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

Brain Network Topology and Structural–Functional Connectivity Coupling Mediate the Association Between Gut Microbiota and Cognition

Metagenomic association analysis of cognitive impairment in community-dwelling older adults

Unraveling the gut‐brain connection: The association of microbiota‐linked structural brain biomarkers with behavior and mental health

Metabolic and Neural Mechanisms Underlying the Associations Between Gut Bacteroides and Cognition: A Large-Scale Functional Network Connectivity Study

Strategy for an Association Study of the Intestinal Microbiome and Brain Metabolome Across the Lifespan of Rats.

Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis

Association of the Gut Microbiota With Cognitive Function in Midlife

Altered Microbiomes Distinguish Alzheimer's Disease from Amnestic Mild Cognitive Impairment and Health in a Chinese Cohort.

Alterations of Gut Microbiota Are Associated with Brain Structural Changes in the Spectrum of Alzheimer's Disease: the SILCODE Study in Hainan Cohort

Gut Microbiota and Targeted Biomarkers Analysis in Patients With Cognitive Impairment

Large‐scale functional network connectivity mediate the associations of gut microbiota with sleep quality and executive functions

The Progress of Gut Microbiome Research Related to Brain Disorders

The gut microbiome is associated with brain structure and function in schizophrenia

Gut microbiota dysbiosis in patients with Alzheimer's disease and correlation with multiple cognitive domains

Causal relationship of gut microbiota and metabolites on cognitive performance: A mendelian randomization analysis

Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder

Gut Microbiota Dysbiosis in Patients with Alzheimer’s Disease and Correlation with Multiple Cognitive Domains

Gut microbiota and cognitive performance: A bidirectional two-sample Mendelian randomization

Disruptions of Gut Microbiota Are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.